ReviewPharmaceuticals (Basel, Switzerland)2022

Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.

Miguel Olivas-Aguirre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.